AbCellera Biologics financial statements

앱셀레라 바이오로직스NASDAQ:ABCL · Nasdaq · Healthcare · sector #16
$13.15-4.57%
2026-10-06 close · prelim

AbCellera Biologics's published financial data is dated 2026-10-04. 2024 revenue was $29M. 2024 operating profit was −$315M.

Reported results

AbCellera Biologics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q